ArticleJCO precision oncology2021

Clinical Outcomes in Non-Small-Cell Lung Cancer Patients Treated With EGFR-Tyrosine Kinase Inhibitors and Other Targeted Therapies Based on Tumor Versus Plasma Genomic Profiling.

Hai T Tran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.